Industry Research Update: New Study Bolsters Kratom's Therapeutic Narrative for Alcohol Reduction

New research indicates that a combination of mitragynine and naltrexone significantly reduces alcohol use in rats, bolstering the scientific narrative around kratom's potential therapeutic applications.
A recent study from University of Houston researchers found that a combination of mitragynine and naltrexone significantly decreased alcohol use in rats, outperforming either substance alone. This research, while preliminary and from animal studies, contributes to a growing body of evidence suggesting kratom's potential therapeutic applications.
- A recent study in rats suggests a combination of mitragynine and naltrexone significantly reduces alcohol consumption, more so than either substance alone, potentially opening new avenues for therapeutic applications.
- This research, alongside previous human and animal studies, reinforces the growing scientific interest in kratom's potential benefits, positively influencing public perception and advocacy efforts for the industry.
- The study implicitly highlights the ongoing challenges for scientific research into kratom due to its Schedule I classification in some jurisdictions, underscoring the need for regulatory reform to facilitate further investigation. Source: Kratom Science via Sentinel Newsroom
Related
- Kratom legal status map
- Latest news & updates
- KratomBans API — checkout validation & compliance for merchants
Get email alerts when kratom laws change in your area.
Email AlertsMerchants: Add legal status to your store →
KRATOMBANSAffiliate relationships do not influence legislative reporting.